138 related articles for article (PubMed ID: 36089739)
1. Dual-Modal Nanoscavenger for Detoxification of Organophosphorus Compounds.
Zou S; Wang B; Wang Q; Liu G; Song J; Zhang F; Li J; Wang F; He Q; Zhu Y; Zhang L
ACS Appl Mater Interfaces; 2022 Sep; 14(37):42454-42467. PubMed ID: 36089739
[TBL] [Abstract][Full Text] [Related]
2. Cell-Membrane-Cloaked Oil Nanosponges Enable Dual-Modal Detoxification.
Chen Y; Zhang Y; Zhuang J; Lee JH; Wang L; Fang RH; Gao W; Zhang L
ACS Nano; 2019 Jun; 13(6):7209-7215. PubMed ID: 31117372
[TBL] [Abstract][Full Text] [Related]
3. Differences in biological activities between recombinant human paraoxonase 1 (rhPON1) subtype isozemys R/Q as antidotes against organophosphorus poisonings.
Cui Y; Zhao M; Han L
Toxicol Lett; 2020 Jun; 325():51-61. PubMed ID: 31981688
[TBL] [Abstract][Full Text] [Related]
4. Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds.
Zhang Y; He J; Shen L; Wang T; Yang J; Li Y; Wang Y; Quan D
J Control Release; 2021 Jan; 329():1117-1128. PubMed ID: 33096123
[TBL] [Abstract][Full Text] [Related]
5. Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon.
Petrikovics I; Papahadjopoulos D; Hong K; Cheng TC; Baskin SI; Jiang J; Jaszberenyi JC; Logue BA; Szilasi M; McGuinn WD; Way JL
Toxicol Sci; 2004 Feb; 77(2):258-62. PubMed ID: 12857941
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of organophosphorus hydrolase and oxime on the reactivation rate of diethylphosphoryl-acetylcholinesterase conjugates.
Ashani Y; Leader H; Rothschild N; Dosoretz C
Biochem Pharmacol; 1998 Jan; 55(2):159-68. PubMed ID: 9448738
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of medical countermeasures against organophosphorus compounds: the value of experimental data and computer simulations.
Worek F; Aurbek N; Herkert NM; John H; Eddleston M; Eyer P; Thiermann H
Chem Biol Interact; 2010 Sep; 187(1-3):259-64. PubMed ID: 19917271
[TBL] [Abstract][Full Text] [Related]
8. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
9. Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase.
Luo C; Leader H; Radic Z; Maxwell DM; Taylor P; Doctor BP; Saxena A
Biochem Pharmacol; 2003 Aug; 66(3):387-92. PubMed ID: 12907237
[TBL] [Abstract][Full Text] [Related]
10. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
[TBL] [Abstract][Full Text] [Related]
11. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Albuquerque EX; Pereira EF; Aracava Y; Fawcett WP; Oliveira M; Randall WR; Hamilton TA; Kan RK; Romano JA; Adler M
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13220-5. PubMed ID: 16914529
[TBL] [Abstract][Full Text] [Related]
12. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
[TBL] [Abstract][Full Text] [Related]
13. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.
Gorecki L; Korabecny J; Musilek K; Malinak D; Nepovimova E; Dolezal R; Jun D; Soukup O; Kuca K
Arch Toxicol; 2016 Dec; 90(12):2831-2859. PubMed ID: 27582056
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.
Reiner E; Radić Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
16. A theoretical model of the competition between hydrolase and carboxylesterase in protection against organophosphorus poisoning.
Sweeney RE; Maxwell DM
Math Biosci; 1999 Sep; 160(2):175-90. PubMed ID: 10472753
[TBL] [Abstract][Full Text] [Related]
17. Is it possible to reverse aged acetylcholinesterase inhibited by organophosphorus compounds? Insight from the theoretical study.
An Y; Zhu Y; Yao Y; Liu J
Phys Chem Chem Phys; 2016 Apr; 18(14):9838-46. PubMed ID: 27000635
[TBL] [Abstract][Full Text] [Related]
18. Nanoscavenger provides long-term prophylactic protection against nerve agents in rodents.
Zhang P; Liu EJ; Tsao C; Kasten SA; Boeri MV; Dao TL; DeBus SJ; Cadieux CL; Baker CA; Otto TC; Cerasoli DM; Chen Y; Jain P; Sun F; Li W; Hung HC; Yuan Z; Ma J; Bigley AN; Raushel FM; Jiang S
Sci Transl Med; 2019 Jan; 11(473):. PubMed ID: 30602537
[TBL] [Abstract][Full Text] [Related]
19. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds.
Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D
Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
